Although exogenous irisin has been suggested to increase energy expenditure and reduce high fat diet-induced obesity and insulin resistance [1], it is still unclear whether exogenous irisin administration ameliorates vascular dysfunction which is induced by abnormal metabolism, and whether irisin may induce vasoconstriction or vasodilation in the vasculature. The gene discussed is FNDC5; the disease is Obesity.